Sleep Apnea News and Research

RSS

HGNS increases airflow during sleep in patients with OSA

Hypoglossal nerve stimulation (HGNS) produced marked dose-related increases in airflow in obstructive sleep apnea (OSA) patients without arousing them from sleep, according to a new study from the Johns Hopkins Sleep Disorders Center.

25 Nov 2011

Einstein, Montefiore experts available to discuss effects of radiation dose and exposure

Experts from Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University are available for interviews on topics ranging from effects of radiation dose and exposure to MRI imaging to detect brain damage in soccer players due to "heading" and cancer post-treatment imaging during the annual Radiological Society of North America Scientific Assembly.

24 Nov 2011

CWRU receives NHLBI grant to study sleep apnea as possible cause of AF

Case Western Reserve University School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart rhythm.

22 Nov 2011

Cyberonics net sales increase 13% to $53.7M for second quarter 2012

Cyberonics, Inc. today announced results for the quarter ended October 28, 2011.

19 Nov 2011

New white paper on potential role of EBTs in treating obesity

The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like Type 2 diabetes.

18 Nov 2011

Cortex third quarter net loss increases to $1,175,000

Cortex Pharmaceuticals, Inc. reported a net loss of approximately $1,175,000, or $0.01 per share, for the quarter ended September 30, 2011, compared with a net loss of approximately $528,000, or $0.01 per share, for the corresponding prior year quarter.

14 Nov 2011

State roundup: Storms' huge impact on health care; Brooklyn's hospital quest; Calif. election results

Only a few private hospitals have survived in neighborhoods like Bedford-Stuyvesant, Brownsville and Bushwick to serve poor patients like them. Now all are in such dire financial shape that a small group of veteran health care planners appointed by Gov. Andrew M. Cuomo is debating last-ditch measures to save them.

10 Nov 2011

Obesity raises risk of injury and related woes: Report

The Australian Institute of Health and Welfare said in its report, “Obesity and Injury in Australia: a Review of the Literature”, that in spite of the findings being mixed, the probability of falls, trips or stumbles rise with obesity. However, the Institute's James Harrison says the increased risk of injury from falls in the obese may be somewhat offset by the better cushioning body fat provides.

6 Nov 2011

Single-parent status, household income linked to increased rate of hospital readmissions of asthmatic children

Financial strain and competing priorities at home may contribute to the greater number of hospital readmissions of children with asthma from single-parent homes compared to dual-parent households, according to a new study presented at the American College of Allergy, Asthma and Immunology Annual Meeting in Boston, Nov. 3-8.

5 Nov 2011

FDA accepts VIVUS' Qnexa NDA for filing and review

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the New Drug Application (NDA) for Qnexa to treat obesity. The company resubmitted the NDA on October 17, 2011.

4 Nov 2011

Loneliness can affect sleep: Sleep

A new study from the American Academy of Sleep Medicine published in the Nov. 1 issue of the journal Sleep, suggests that loneliness could be significantly associated with sleep fragmentation, but not sleep duration or subjective sleep measures.

3 Nov 2011

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.

31 Oct 2011

Thyroidectomy reduces snoring associated with obstructive sleep apnea

Obstructive sleep apnea, caused by narrowing or blockage of the airways when a person is asleep affects about 20% of the population. Typically a person with OSA will begin snoring loudly on falling asleep. If not treated, obstructive sleep apnea (OSA) can increase a person's risk of death. It is not clear whether an enlarged thyroid gland, known as a goiter, can worsen cause or worsen symptoms of OSA by compressing the airway.

29 Oct 2011

Apnex Medical's HGNS System receives CE Mark approval for treatment of OSA

Apnex Medical, Inc., has received CE Mark approval for its Hypoglossal Nerve Stimulation System for use by people who suffer from obstructive sleep apnea.

28 Oct 2011

Late pregnancy snoring could harm mother and baby alike

Nearly half of pregnant women may develop snoring by their final trimester and this could lead to dangerous health problems for mother and baby, Australian sleep researchers have shown. According to professor of medicine, Colin Sullivan, research found woman who started snoring during the later stages of pregnancy were at increased risk of developing high blood pressure.

27 Oct 2011

Watson receives FDA approval for Androderm lower-dose formulations

Watson Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved its Androderm (testosterone transdermal system) 2 mg and 4 mg formulation.

21 Oct 2011

VIVUS announces Qnexa NDA resubmission for treatment of obesity

VIVUS, Inc. today announced that the company has resubmitted the New Drug Application (NDA) for Qnexa to the U.S. Food and Drug Administration.

18 Oct 2011

NovaSom enters unique agreement with HealthAmerica to treat sleep disorders

NovaSom, Inc., the market leader in technology-driven, payer-aligned cost-saving solutions for obstructive sleep apnea (OSA) management, today announced it has entered a preferred relationship to aid HealthAmerica with managing its sleep disorder diagnostic expenses.

11 Oct 2011

Noninvasive method can detect sudden infant death syndrome, sleep apnea

University of Utah engineers who built wireless networks that see through walls now are aiming the technology at a new goal: noninvasively measuring the breathing of surgery patients, adults with sleep apnea and babies at risk of sudden infant death syndrome.

19 Sep 2011

Multiple abstracts on QNEXA presented at 47th EASD

VIVUS, Inc. today announced that multiple abstracts were presented at the 47th European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal. The presentations highlighted the long-term beneficial effects of QNEXA treatment in metabolically-impaired patients with prediabetes, diabetes, and metabolic syndrome.

17 Sep 2011